We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Hantavirus Rapid Test Paves Way for Early Outbreak Control

By LabMedica International staff writers
Posted on 29 Feb 2024
Print article
Image: The approach of the study was rooted in adoption of NGS technologies with spotlight on MinION nanopore sequencer (Photo courtesy of Oxford Nanopore)
Image: The approach of the study was rooted in adoption of NGS technologies with spotlight on MinION nanopore sequencer (Photo courtesy of Oxford Nanopore)

Orthohantaviruses, known for their ability to cause hemorrhagic fever with renal syndrome (HFRS) in Eurasia and hantavirus cardiopulmonary syndrome in the Americas, are significant public health concerns due to their high transmission rates and impact on health. These zoonotic pathogens have been the focus of extensive research, particularly for controlling outbreaks and devising intervention strategies. In South Korea's Gyeonggi Province, a notable number of HFRS cases have been reported, highlighting the need for diligent epidemiological surveillance and a deeper understanding of orthohantaviruses' genomic diversity. Now, new research has unveiled the potential of cost-efficient Flongle sequencing for rapid hantavirus genome-based diagnostics and phylogeographical surveillance.

A research team from Korea University College of Medicine (Seoul, South Korea) undertook a study in the Gyeonggi Province to investigate the prevalence, viral loads, and genetic variations of Hantaan orthohantavirus (HTNV). They utilized Flongle sequencing, an innovative and budget-friendly approach, for detecting HTNV genomes, emphasizing the use of the Oxford MinION nanopore sequencer in the field of next-generation sequencing technologies. The team's methodology included capturing rodents and shrews from various areas using live traps, followed by mitochondrial DNA analysis, indirect immunofluorescence antibody tests, and other molecular methods for species identification and virus detection.

During the 2017-2018 surveillance in Gyeonggi Province, a substantial presence of Apodemus agrarius, a common rodent species, was noted. Among these, 12.4% were found to be seropositive for HTNV, indicating the virus's prevalence in the region. The use of Flongle sequencing was key in acquiring full-length genomic sequences from positive samples, achieving high coverage rates and accuracy on par with Illumina sequencing. The study's phylogeographical analysis revealed distinct evolutionary divergence among HTNV's tripartite genomes, with genetic clustering and evolutionary pattern incongruences highlighting the virus's segment-specific evolution.

While the study offers critical insights, the researchers acknowledge limitations like the need for enhanced sensitivity testing of Flongle-based diagnostics and the requirement for broader genomic and epidemiological data in certain endemic areas. This research represents a major advancement in the understanding of orthohantaviruses and sets the stage for more focused strategies to combat HFRS outbreaks. The findings underscore the importance of genomics in disease surveillance and hold promise for improved responses to emerging infectious diseases.

“We developed a rapid and sensitive on-site diagnostic using a nanopore-based Flongle chip with a reasonable cost of around $100. This approach enables virtually whole-genome sequencing of HTNV within 3 hours,” said Prof. Jin-Won Song from Korea University College of Medicine who led the research. "We believe our findings provide important insights into on-site diagnostics, genome-based surveillance, and the evolutionary dynamics of orthohantaviruses to mitigate hantaviral outbreaks in HFRS-endemic areas in the ROK. Our study pioneers the integration of cost-efficient Flongle sequencing into hantavirus diagnostics, offering a rapid and accurate tool for on-site detection. This innovation has the potential to transform how we approach and manage hantavirus outbreaks."

Related Links:
Korea University College of Medicine 

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more